Megan Holdings faces class action after 93.4% collapse in MGN shares

Investors face a Sept. 8 lead plaintiff deadline in a class action against Megan Holdings (MGN) after its stock collapsed 93.4% in one day.

The complaint, filed in the U.S. District Court for the Southern District of New York, alleges the aquaculture company was a vehicle for a pump-and-dump scheme, according to the lawsuit Mundy v. Megan Holdings Limited, et al. (Case No. 1:26-cv-05754).

MGN shares surged more than 400% from $1.23 on Feb. 25 to an intraday high of $5.18 on March 25, 2026, on no fundamental news, before falling $3.96 to close at $0.28 the next day. The company raised $5 million in its Sept. 29, 2025 IPO, selling 1.25 million shares at $4.00 apiece.

The complaint names the company, CEO Darren Hoo, CFO Ng Kai Tie, auditor WWC P.C., and sole underwriter D. Boral Capital LLC as defendants. It asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, plus Sections 11, 12(a)(2), and 15 of the Securities Act of 1933.

The lawsuit alleges impersonators acting as financial advisors touted MGN stock in online forums and social media with baseless claims, driving the buying frenzy. The IPO prospectus promised a proprietary Smart Farming System, international expansion into Indonesia, and a one-stop aquaculture solution, while concealing material weaknesses in internal accounting controls and the underwriter's pattern of presiding over similar microcap collapses. D. Boral Capital had underwritten IPOs for Park Ha Biological Technology (down 94%), Masonglory Limited (down 97.6%), and Phoenix Asia Holding, which fell from $133.12 to $17.60 in one trading day.

The complaint also alleges CEO Hoo, who controlled 61.97% of shares after the IPO, had the power to prevent the dissemination of misleading statements. The prospectus's risk factors warned only in generic terms about volatility and internal control failures, framing already-existing weaknesses as hypothetical future risks, according to the lawsuit.

The deadline to seek lead plaintiff appointment is Sept. 8, 2026. Investors who purchased during the class period — Sept. 26, 2025 through March 25, 2026 — may be eligible for recovery without serving as lead plaintiff, and there is no minimum loss threshold.

The collapse leaves MGN trading well below its $0.28 close, with the stock yet to recover. Investors will watch the court's lead plaintiff appointment and any subsequent settlement or delisting action as the case progresses. The case also raises questions about gatekeeper oversight of microcap IPOs, a segment that has drawn repeated regulatory scrutiny over manipulation-driven collapses.

This article is for informational purposes only and does not constitute investment advice.